The pharmaceutical sector is seeing a significant shift in blood sugar care with the arrival of GLP-1 transdermal devices. These innovative methods offer a likely simple option to subcutaneous injections for individuals living with type 2 diabetes. By circumventing the need for frequent injections, GLP-1 patches promise to enhance user adherence… Read More